• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亮氨酸27 - 促生长激素释放因子(1 - 29)氨基端及其D - 丙氨酸2和去(酪氨酸1 - 丙氨酸2)类似物的1H核磁共振分析与体外生物活性

1H NMR analysis and in vitro bioactivity of Leu27-bGRF(1-29)NH2 and its D-Ala2 and des-(Tyr1-Ala2)-analogs.

作者信息

Kloosterman D A, Scahill T A, Hillman R M, Cleary D L, Kubiak T M

机构信息

Physical and Analytical Chemistry Research, Upjohn Company, Kalamazoo, MI 49001.

出版信息

Pept Res. 1991 Mar-Apr;4(2):72-8.

PMID:1667740
Abstract

Relative growth hormone-releasing potencies of bovine growth hormone-releasing factor (bGRF) analogs bGRF(1-44)NH2 (I), Leu27-bGRF(1-29)NH2 (II) and D-Ala2, Leu27-bGRF(1-29)NH2 (III) in in vitro bovine anterior pituitary cell cultures were determined to be 100%, 48% and 77%, respectively. The potencies of II and III, although numerically different, were not statistically different. Leu27-bGRF(3-29)NH2 (IV) was approximately 10,000 times less potent than 1. 1H NMR studies of peptides II, III and IV in 35% d3-2,2,2-trifluorethanol (TFE)/65% phosphate buffer at pH 4 revealed very similar, highly helical secondary structures in the 8-29 region, with only subtle differences at the N-termini. This lack of correlation between secondary structure in solution and in vitro bioactivity suggests that either 1) the biological conformations induced at the GRF receptor for II and III vs. IV are different from those generated in TFE/buffer, 2) similar secondary structures may be necessary but not sufficient for the observed bioactivity or 3) residues 1 and 2 of analogs II and III are important contact residues crucial for effective GRF-receptor interaction.

摘要

在体外牛垂体前叶细胞培养中,测定了牛生长激素释放因子(bGRF)类似物bGRF(1 - 44)NH₂(I)、Leu²⁷ - bGRF(1 - 29)NH₂(II)和D - Ala², Leu²⁷ - bGRF(1 - 29)NH₂(III)的相对生长激素释放效力,分别为100%、48%和77%。II和III的效力虽然在数值上不同,但在统计学上没有差异。Leu²⁷ - bGRF(3 - 29)NH₂(IV)的效力比I低约10000倍。在pH 4的35% d₃ - 2,2,2 - 三氟乙醇(TFE)/65%磷酸盐缓冲液中对肽II、III和IV进行的¹H NMR研究表明,在8 - 29区域具有非常相似的高度螺旋二级结构,仅在N端有细微差异。溶液中的二级结构与体外生物活性之间缺乏相关性表明,要么1)II和III与IV在生长激素释放因子(GRF)受体上诱导的生物学构象与在TFE/缓冲液中产生的不同,2)相似的二级结构对于观察到的生物活性可能是必要的,但不是充分的,要么3)类似物II和III的第1和第2位残基是有效GRF - 受体相互作用的重要接触残基。

相似文献

1
1H NMR analysis and in vitro bioactivity of Leu27-bGRF(1-29)NH2 and its D-Ala2 and des-(Tyr1-Ala2)-analogs.亮氨酸27 - 促生长激素释放因子(1 - 29)氨基端及其D - 丙氨酸2和去(酪氨酸1 - 丙氨酸2)类似物的1H核磁共振分析与体外生物活性
Pept Res. 1991 Mar-Apr;4(2):72-8.
2
In vitro metabolic degradation of a bovine growth hormone-releasing factor analog Leu27-bGRF(1-29)NH2 in bovine and porcine plasma. Correlation with plasma dipeptidylpeptidase activity.牛生长激素释放因子类似物Leu27-bGRF(1-29)NH2在牛和猪血浆中的体外代谢降解。与血浆二肽基肽酶活性的相关性。
Drug Metab Dispos. 1989 Jul-Aug;17(4):393-7.
3
Pegylated peptides. IV. Enhanced biological activity of site-directed pegylated GRF analogs.聚乙二醇化肽。IV. 定点聚乙二醇化生长激素释放因子类似物的增强生物活性。
Int J Pept Protein Res. 1995 Sep-Oct;46(3-4):253-64.
4
Position 2 and position 2/Ala15-substituted analogs of bovine growth hormone-releasing factor (bGRF) with enhanced metabolic stability and improved in vivo bioactivity.牛生长激素释放因子(bGRF)的2位和2位/丙氨酸15取代类似物,具有增强的代谢稳定性和改善的体内生物活性。
J Med Chem. 1993 Apr 2;36(7):888-97. doi: 10.1021/jm00059a014.
5
Effect of secondary structure on the rate of deamidation of several growth hormone releasing factor analogs.二级结构对几种生长激素释放因子类似物脱酰胺化速率的影响。
Int J Pept Protein Res. 1993 Dec;42(6):497-503. doi: 10.1111/j.1399-3011.1993.tb00356.x.
6
Potent long-acting alkylated analogs of growth hormone-releasing factor.生长激素释放因子的强效长效烷基化类似物。
Pept Res. 1988 Sep-Oct;1(1):36-41.
7
Effects of growth hormone-releasing hormone (GRF) analogs, bovine and rat GRF on growth hormone secretion in cattle in vivo.生长激素释放激素(GRF)类似物、牛和大鼠GRF对牛体内生长激素分泌的影响。
Endocr J. 1997 Dec;44(6):811-7. doi: 10.1507/endocrj.44.811.
8
Metabolism of mouse growth hormone-releasing factor, mGRF(1-42)OH, and selected analogs from the bovine GRF series in mouse and bovine plasma in vitro.小鼠生长激素释放因子mGRF(1 - 42)OH及牛生长激素释放因子系列中选定类似物在小鼠和牛血浆中的体外代谢
Pept Res. 1994 May-Jun;7(3):153-61.
9
Effects of growth hormone (GH)-releasing hormone and its analogs on GH secretion from cultured adenohypophysial cells in cattle.生长激素释放激素及其类似物对牛培养腺垂体细胞生长激素分泌的影响。
Domest Anim Endocrinol. 1997 Jan;14(1):39-46. doi: 10.1016/s0739-7240(96)00096-3.
10
Human growth hormone-releasing hormone hGHRH(1-29)-NH2: systematic structure-activity relationship studies.人生长激素释放激素hGHRH(1 - 29)-NH2:系统的构效关系研究。
J Med Chem. 1998 Feb 26;41(5):717-27. doi: 10.1021/jm970618s.

引用本文的文献

1
Probing the helical content of growth hormone-releasing factor analogs using electrospray ionization mass spectrometry.利用电喷雾电离质谱法探测生长激素释放因子类似物的螺旋含量。
J Am Soc Mass Spectrom. 1993 Aug;4(8):646-51. doi: 10.1016/1044-0305(93)85029-W.
2
The mass spectrometry of helical unfolding in peptides.肽螺旋展开的质谱分析。
J Am Soc Mass Spectrom. 1994 May;5(5):425-33. doi: 10.1016/1044-0305(94)85058-5.
3
Inhibition of calmodulin-dependent myosin light-chain kinase by growth-hormone-releasing factor and vasoactive intestinal peptide.
生长激素释放因子和血管活性肠肽对钙调蛋白依赖性肌球蛋白轻链激酶的抑制作用。
Biochem J. 1994 Jun 15;300 ( Pt 3)(Pt 3):901-5. doi: 10.1042/bj3000901.